Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Incorrect about hormone treatment in prostatic cancer].
Fosså SD, Egey A, Haukaas SA, Angelsen A, Klepp O, Berge V, Axcrona K, Lilleby W. Fosså SD, et al. Among authors: klepp o. Tidsskr Nor Laegeforen. 2009 Feb 26;129(5):429. doi: 10.4045/tidsskr.08.0649. Tidsskr Nor Laegeforen. 2009. PMID: 19247406 Free article. Norwegian. No abstract available.
Modern treatment of metastatic prostate cancer.
Holm HV, Dahl AA, Klepp OH, Fosså SD. Holm HV, et al. Among authors: klepp oh. Tidsskr Nor Laegeforen. 2017 Jun 6;137(11):803-805. doi: 10.4045/tidsskr.16.0265. eCollection 2017 Jun. Tidsskr Nor Laegeforen. 2017. PMID: 28597635 Free article. Review. English, Norwegian.
[Re: Different guidelines for treatment of prostate cancer].
Solberg A, Angelsen A, Berge V, Lilleby W, Iversen J, Klepp O, Brennhovd B, Johannessen D, Nygård Y, Larsen K, Stensvold A. Solberg A, et al. Among authors: klepp o. Tidsskr Nor Laegeforen. 2015 Jun 30;135(12-13):1105. doi: 10.4045/tidsskr.15.0652. eCollection 2015 Jun 30. Tidsskr Nor Laegeforen. 2015. PMID: 26130530 Free article. Norwegian. No abstract available.
H.V. Holm og medarbeidere svarer.
Holm HV, Dahl AA, Klepp OH, Fosså SD. Holm HV, et al. Among authors: klepp oh. Tidsskr Nor Laegeforen. 2017 Aug 21;137(14-15). doi: 10.4045/tidsskr.17.0579. Print 2017 Aug 22. Tidsskr Nor Laegeforen. 2017. PMID: 28828789 Free article. Norwegian. No abstract available.
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.
Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, Lund JA, Tasdemir I, Hoyer M, Wiklund F, Fosså SD; Scandinavian Prostate Cancer Group Study 7; Swedish Association for Urological Oncology 3. Widmark A, et al. Among authors: klepp o. Lancet. 2009 Jan 24;373(9660):301-8. doi: 10.1016/S0140-6736(08)61815-2. Epub 2008 Dec 16. Lancet. 2009. PMID: 19091394 Free article. Clinical Trial.
Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7.
Fosså SD, Wiklund F, Klepp O, Angelsen A, Solberg A, Damber JE, Hoyer M, Widmark A; The Scandinavian Prostate Cancer Group-7 Investigators. Fosså SD, et al. Among authors: klepp o. Eur Urol. 2016 Oct;70(4):684-691. doi: 10.1016/j.eururo.2016.03.021. Epub 2016 Mar 26. Eur Urol. 2016. PMID: 27025586 Clinical Trial.
[Biological markers in cancer of the testis].
Lotsberg J, Fosså SD, Klepp O, Orjasaeter H, Torjesen PA. Lotsberg J, et al. Among authors: klepp o. Tidsskr Nor Laegeforen. 1980 Apr 30;100(12):688-90. Tidsskr Nor Laegeforen. 1980. PMID: 6158120 Norwegian. No abstract available.
Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial.
Fransson P, Lund JA, Damber JE, Klepp O, Wiklund F, Fosså S, Widmark A; Scandinavian Prostate Cancer Group Study 7; Swedish Association for Urological Oncology 3. Fransson P, et al. Among authors: klepp o. Lancet Oncol. 2009 Apr;10(4):370-80. doi: 10.1016/S1470-2045(09)70027-0. Epub 2009 Mar 13. Lancet Oncol. 2009. PMID: 19286422 Clinical Trial.
142 results